PHARMING GROUP NV's ticker is PHAR and the CUSIP is 71716E105. A total of 5 filers reported holding PHARMING GROUP NV in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,500 | -2.1% | 2,500 | 0.0% | 0.00% | – |
| Q2 2023 | $29,125 | -13.7% | 2,500 | 0.0% | 0.00% | – |
| Q1 2023 | $33,750 | -54.0% | 2,500 | -62.4% | 0.00% | – |
| Q4 2022 | $73,338 | +11.1% | 6,649 | -1.5% | 0.00% | – |
| Q3 2022 | $66,000 | +200.0% | 6,750 | +170.0% | 0.00% | – |
| Q2 2022 | $22,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | -8.3% | 2,500 | -1.9% | 0.00% | – |
| Q3 2021 | $24,000 | -17.2% | 2,548 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | +2800.0% | 2,548 | +5208.3% | 0.00% | – |
| Q1 2021 | $1,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cowen Prime Advisors LLC | 15,850 | $142,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 2,500 | $22,000 | 0.00% |
| UBS Group AG | 1,262 | $11,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 974 | $9,000 | 0.00% |